Epstein Secrets

EFTA00130083 NMS LI S Toxicology Report Report Issued 08/22/2019 17:09 Phone email: PhD. F-ADFT, DADCC-TC, Laboratory Director To: 10074 New York Office of Chief Medical Examiner Attn: Department of Toxicology 520 First Avenue New York, NY 10016 Positive Findings: CONFIDENTIAL Patient Name FT19-03508 M19-019432

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Compound 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/mL CUMYL-THPINACA 0.10 ng/mL 5

2 ornagnmstabs.com Robert A. likldieberg, PhD, Fair; DABCC-TC, Laboratory lIrecior Toxicology Report Report issued 08/22/2019 17:09 To: 10074 New York Office of Chief Medical Examiner Attn: Department of Toxicology 520 First Avenue New York, NY 10016 Positive Findings: Patient Name FT19-03508 M19-019432 Patient ID

thetic Cernabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquld Chromatography/Tandem Mass Spectrometry CITFtAP (LC-MS/MS QTRAP) for Comnnmstd 4-cyano-CUMYL-BINACA 4-fluoro-MOMB-BINACA 5-fluoro-EDNIB-PINACA 5-fluoro-MOMB-PICA 5-fluoro-MDMB-PINACA 5-fluoro- EMB-P

19044-2208 Phone: Robert A. PAIddlebem. PhD. F-ABFT, DABCC-TC, Laboratory Director Toxicology Report Report Issued 08722/2019 17:09 To: 10074 New York Office of Chief Medical Examiner of Toxicology 0016 Positive Findings: Patient Name Patient ID Chain Age Not Given Gender Workorder Pago 1 of 2 CONFIDENTIAL FT19

ynthetic Cannabinotds Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for aaranstuad Ret Limit COOMBS' Rot—Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 ng/m

il: [email protected] Robert A. MIddleberg, PhD, PABFT, DABCC-TC, Laboratory Director Toxicology Report Report Issued 08/22/2019 17:09 To: 10074 New York Office of Chief Medical Examiner Attn: Department of Toxicology 520 First Avenue New York, NY 10016 Positive Findings: Patient Name FT19-03508 M19-019432 Patient ID

ynthetic Carnabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatographyrfandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Comm-km(1 Bal .Old command Eat-Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-ftuoro-PADMB-BINACA 0.10 ng/mL

labs.com CONFIDENTIAL t b)(S); (b)(?)(C) jo. F-ABFT, DABCC-TC, Laboratory Director Toxicology Report Report Issued 08/22/201917:09 To: 10074 New York Office of Chief Medical Examiner Attn: Department of Toxicology 520 First Avenue New York, NY 10016 Positive Findings: Patient Name Patient ID Chain FT19-03508 M19-0

ynthetic Cannabinaids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid ChromatographyfTandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for. Compound Rpt Limit comccund Bgt Liroit 4-<:yano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-Huoro-MDMB-BINACA 0.10 ng/

Report Issued 08/22/2019 17:09 NMS Labs 200 Welsh Road, Horsham, PA 19044-2208 PhoneNaas: ( e-mail: DABCC-TC, Laboratory Director To: 10074 New York Office of Chief Medical Examiner Atha. Dopat i mot of Toxicology 520 First Avenue New York, NY 10016 Positive Findings: Patient Name Patient ID Chain Age Not Given

ynthetic Cannabinoids Screen (2019 Scope), Blood - Femoral Blood -Analysis by High Performance Liquid Chromatography/Tandem Mass Spectrometry QTRAP (LC-MS/MS QTRAP) for Compound Rid I iat C.00.12011XL Rot Limit 4-cyano-CUMYL-BINACA 0.10 ng/mL AMB-FUBINACA 1.0 ng/mL 4-fluoro-MDMB-BINACA 0.10 n